Literature DB >> 18602789

Tyrosine promotes oxidative stress in cerebral cortex of young rats.

Angela M Sgaravatti1, Bethânia A Vargas, Bernardo R Zandoná, Kátia B Deckmann, Francieli J Rockenbach, Tarsila B Moraes, José M Monserrat, Mirian B Sgarbi, Carolina D Pederzolli, Angela T S Wyse, Clóvis M D Wannmacher, Moacir Wajner, Carlos Severo Dutra-Filho.   

Abstract

Tyrosine accumulates in inborn errors of tyrosine catabolism, especially in tyrosinemia type II, where tyrosine levels are highly elevated in tissues and physiological fluids of affected patients. In tyrosinemia type II, high levels of tyrosine are correlated with eyes, skin and central nervous system disturbances. Considering that the mechanisms of brain damage in these disorders are poorly known, in the present study, we investigated whether oxidative stress is elicited by l-tyrosine in cerebral cortex homogenates of 14-day-old Wistar rats. The in vitro effect of 0.1-4.0mM l-tyrosine was studied on the following oxidative stress parameters: total radical-trapping antioxidant potential (TRAP), total antioxidant reactivity (TAR), ascorbic acid content, reduced glutathione (GSH) content, spontaneous chemiluminescence, thiobarbituric acid-reactive substances (TBA-RS), thiol-disulfide redox state (SH/SS ratio), protein carbonyl content, formation of DNA-protein cross-links, and the activities of the enzymes superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glucose-6-phosphate dehydrogenase (G6PDH). TRAP, TAR, ascorbic acid content, SH/SS ratio and CAT activity were significantly diminished, while formation of DNA-protein cross-link was significantly enhanced by l-tyrosine in vitro. In contrast, l-tyrosine did not affect the other parameters of oxidative stress evaluated. These results indicate that l-tyrosine decreases enzymatic and non-enzymatic antioxidant defenses, changes the redox state and stimulates DNA damage in cerebral cortex of young rats in vitro. This suggests that oxidative stress may represent a pathophysiological mechanism in tyrosinemic patients, in which this amino acid accumulates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602789     DOI: 10.1016/j.ijdevneu.2008.05.007

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  23 in total

1.  Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC.

Authors:  Eva Thimm; Renate Richter-Werkle; Gudrun Kamp; Bettina Molke; Diran Herebian; Dirk Klee; Ertan Mayatepek; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2011-11-09       Impact factor: 4.982

2.  Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Cell Biochem       Date:  2012-02-05       Impact factor: 3.396

3.  Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Samira Dal-Toé de Prá; Leticia B Wessler; Patricia F Schuck; Giselli Scaini; Andreza Fabro de Bem; Carlos H Blum-Silva; Flávio H Reginatto; Jade de Oliveira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-11-08       Impact factor: 3.584

4.  Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Joyce Rebelo; Adriani P Damiani; Maiara Pereira; Vanessa M Andrade; Fernanda F Gava; Samira S Valvassori; Patricia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-03-18       Impact factor: 3.584

5.  Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.

Authors:  Brena P Teodorak; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Letícia J Teixeira; Joyce Rebelo; Samira D T De Prá; Neila Zeni; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-06       Impact factor: 3.584

6.  The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility.

Authors:  Gabriela K Ferreira; Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Leticia J Teixeira; Isabella T Mota; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-25       Impact factor: 3.584

7.  Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.

Authors:  Gabriela K Ferreira; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Lislaine S Borges; Júlia S Vieira; Larissa S Constantino; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2012-07-31       Impact factor: 3.911

8.  Etiological analysis of neurodevelopmental disabilities: single-center eight-year clinical experience in south China.

Authors:  Li Guo; Bing-Xiao Li; Mei Deng; Fang Wen; Jian-Hui Jiang; Yue-Qiu Tan; Yuan-Zong Song; Zhen-Huan Liu; Chun-Hua Zhang; Keiko Kobayashi; Zi-Neng Wang
Journal:  J Biomed Biotechnol       Date:  2010-09-26

9.  L-tyrosine induces DNA damage in brain and blood of rats.

Authors:  Samira D T De Prá; Gabriela K Ferreira; Milena Carvalho-Silva; Júlia S Vieira; Giselli Scaini; Daniela D Leffa; Gabriela E Fagundes; Bruno N Bristot; Gabriela D Borges; Gustavo C Ferreira; Patrícia F Schuck; Vanessa M Andrade; Emilio L Streck
Journal:  Neurochem Res       Date:  2013-12-03       Impact factor: 3.996

10.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.